Positions

Overview

  • Dr. Locke completed her undergraduate degree in biology and chemistry at Duke University and her medical degree at East Carolina University prior to matriculating to Johns Hopkins Hospital where she received training in general surgery and multi-visceral abdominal transplantation. Dr. Locke completed her Master of Public Health degree with an emphasis in biostatistics and epidemiology at the Johns Hopkins Bloomberg School of Public Health. She joined the surgical faculty at UAB upon completion of her training at Johns Hopkins Hospital. Dr. Locke is a well-funded investigator, and currently holds an NIH K23 Career Development Award and a Clinical Science Faculty Development Grant through the American Society of Transplantation. She has authored 52 articles in peer-reviewed journals and 11 book chapters. Dr. Locke is frequently invited to present her research as a visiting professor at many prestigious academic centers around the US and at international transplant meetings, including the World Transplant Congress, the British Transplantation Society, the American Transplant Congress, and the National Kidney Foundation. In addition, Dr. Locke is an Associate Editor for Transplantation and is a regular peer reviewer for several journals, including the American Journal of Transplantation and the Journal of the American Society of Nephrology to name a few. She is an invited member of the ASTS Providing Better Access to Organs Task Force and Diversity Affairs Committee, the AST Kidney-Pancreas Committee, The Transplantation Society Young Member Committee, and the United Network for Organ Sharing Pediatric Transplant Committee. Dr. Locke is the recipient of numerous honors and has most recently received the American Transplant Congress Young Investigator Award, the Birmingham Business Journal’s Top 40 under 40 Award, and was named one of AL.com’s 2015 Women Who Shape the State.

    Dr. Locke is an abdominal transplant surgeon who specializes in innovative strategies for the transplantation of incompatible organs, disparities in access to and outcomes after solid organ transplantation, and transplantation of HIV-infected end-stage patients. Her research interests include complex statistical analysis and modeling of transplant outcomes and behavioral research focused on health disparities.

    • Selected Publications

    Academic Article

    Year Title Altmetric
    2020 Bariatric surgery to achieve transplant in end-stage organ disease patients: A systematic review and meta-analysis 2020
    2020 Exacerbating Racial Disparities in Kidney Transplant: The Consequences of Geographic Redistribution.  JAMA Surgery.  155:679-681. 2020
    2020 Quantifying Sex-Based Disparities in Liver Allocation.  JAMA Surgery.  155. 2020
    2020 Use of Patient Navigators to Reduce Barriers in Living Donation and Living Donor Transplantation 2020
    2020 Combined Thoracic-Kidney Transplantation Practices May Exacerbate Existing Geographic Disparities in Access to Deceased Donor Kidney Transplantation 2020
    2020 Regional Variation in Appropriateness of Non-Hepatocellular Carcinoma Model for End-Stage Liver Disease Exception.  Journal of The American College of Surgeons.  230:503-512.e8. 2020
    2020 A Qualitative Assessment of the Living Donor Navigator Program to Identify Core Competencies and Promising Practices for Implementation 2020
    2020 Donor-Recipient Relationship and Risk of ESKD in Live Kidney Donors of Varied Racial Groups.  American Journal of Kidney Diseases.  75:333-341. 2020
    2020 Tackling the weight list problem.  American Journal of Transplantation.  20:329-330. 2020
    2020 Enhanced Advocacy and Health Systems Training through Patient Navigation Increases Access to Living-donor Kidney Transplantation.  Transplantation.  122-129. 2020
    2020 Geographic differences in population health and expected organ supply in the Gulf Coast Region of the United States compared to non-Gulf States.  Transplantation.  421-427. 2020
    2020 Impact of Donor Hepatitis C Virus on Kidney Transplant Outcomes for Hepatitis C-positive Recipients in the Direct-acting Antiviral Era: Time to Revise the Kidney Donor Risk Index?.  Transplantation.  1215-1228. 2020
    2020 Positive crossmatch kidney transplantation: State of the art and future perspectives.  Current Pharmaceutical Design.  26:3460-3467. 2020
    2020 Preexisting melanoma and hematological malignancies, prognosis, and timing to solid organ transplantation: A consensus expert opinion statement.  American Journal of Transplantation.  2020
    2020 Pretransplant solid organ malignancy and organ transplant candidacy: A consensus expert opinion statement.  American Journal of Transplantation.  2020
    2020 Redefining the Influence of Ethnicity on Simultaneous Kidney and Pancreas Transplantation Outcomes: A 15-year Single-center Experience.  Annals of Surgery.  271:177-183. 2020
    2020 Social determinants of health: Going beyond the basics to explore racial disparities in kidney transplantation.  Transplantation.  1324-1325. 2020
    2019 Patient Perspectives on Weight Management for Living Kidney Donation.  Journal of Surgical Research.  244:50-56. 2019
    2019 Donation approval among obese living kidney donor candidates: The impact of metabolic syndrome.  Surgery.  166:940-946. 2019
    2019 Get on with it!—A novel allocation strategy to reduce kidney discards.  American Journal of Transplantation.  19:2971-2972. 2019
    2019 Self-reported incident hypertension and long-term kidney function in living kidney donors compared with healthy nondonors.  Clinical Journal of the American Society of Nephrology.  14:1493-1499. 2019
    2019 Mitigating Racial and Sex Disparities in Access to Living Donor Kidney Transplantation: Impact of the Nation's Longest Single-center Kidney Chain.  Annals of Surgery.  270:639-646. 2019
    2019 Obesity and long-term mortality risk among living kidney donors.  Surgery.  166:205-208. 2019
    2019 Patient-reported outcome measures for life participation in kidney transplantation: A systematic review.  American Journal of Transplantation.  19:2306-2317. 2019
    2019 Center variation and risk factors for failure to complete 6 month postdonation follow-up among obese living kidney donors.  Transplantation.  103:1450-1456. 2019
    2019 Ethnic and age disparities in outcomes among liver transplant waitlist candidates.  Transplantation.  103:1425-1432. 2019
    2019 Time for reform in transplant program–specific reporting: AST/ASTS transplant metrics taskforce.  American Journal of Transplantation.  19:1888-1895. 2019
    2019 Establishing a core outcome measure for life participation: A standardized outcomes in nephrology-kidney transplantation consensus workshop report.  Transplantation.  103:1199-1205. 2019
    2019 Mortality and Kidney Transplantation Outcomes Among Hepatitis C Virus–Seropositive Maintenance Dialysis Patients: A Retrospective Cohort Study.  American Journal of Kidney Diseases.  73:815-826. 2019
    2019 Optimal timing of hepatitis C treatment among HIV/HCV coinfected ESRD patients: Pre- vs posttransplant.  American Journal of Transplantation.  19:1806-1819. 2019
    2019 Kidney transplantation in a HIV-positive recipient.  Clinical Journal of the American Society of Nephrology.  14:614-616. 2019
    2019 Disparity in access to kidney allograft offers among transplant candidates with human immunodeficiency virus.  Clinical Transplantation.  33. 2019
    2019 CYP3A5 genotype affects time to therapeutic tacrolimus level in pediatric kidney transplant recipients.  Pediatric Transplantation.  23. 2019
    2018 Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop.  Kidney International.  94:1053-1068. 2018
    2018 Population Health, Ethnicity, and Rate of Living Donor Kidney Transplantation.  Transplantation.  102:2080-2087. 2018
    2018 Can you hear me now? Patient preferences for evaluating kidney transplant centers.  American Journal of Transplantation.  18:2624. 2018
    2018 Population level outcomes and cost-effectiveness of hepatitis C treatment pre- vs postkidney transplantation.  American Journal of Transplantation.  18:2483-2495. 2018
    2018 Response to “It is time to revise the kidney allocation system to restore the pediatric advantage”.  American Journal of Transplantation.  18:2367. 2018
    2018 Expand the pool of living donors for kidney transplantation.  Clinical Journal of the American Society of Nephrology.  13:1142-1143. 2018
    2018 Impact of the new kidney allocation system A2/A2B → B policy on access to transplantation among minority candidates.  American Journal of Transplantation.  18:1947-1953. 2018
    2018 Decreasing deceased donor transplant rates among children (≤6 years) under the new kidney allocation system.  American Journal of Transplantation.  18:1690-1698. 2018
    2018 In Reply to ‘Core Assessment of Predonation Kidney Function: Clarification of the 2017 KDIGO Living Donor Guideline’.  American Journal of Kidney Diseases.  72:155. 2018
    2018 Apolipoprotein L1 and Chronic Kidney Disease Risk in Young Potential Living Kidney Donors.  Annals of Surgery.  267:1161-1168. 2018
    2018 Expanding clarity or confusion? Volatility of the 5-tier ratings assessing quality of transplant centers in the United States.  American Journal of Transplantation.  18:1494-1501. 2018
    2018 Response to: Regarding “HIV protease inhibitors and mortality following kidney transplantation”.  American Journal of Transplantation.  18:1571. 2018
    2018 Evaluation of Kidney Donors: Core Curriculum 2018.  American Journal of Kidney Diseases.  71:737-747. 2018
    2018 Assessing emergency department utilization in the era of population health.  American Journal of Transplantation.  18:777-778. 2018
    2018 Kidney transplantation and waitlist mortality rates among candidates registered as willing to accept a hepatitis C infected kidney.  Transplant Infectious Disease.  20. 2018
    2018 Landscape of ABO-Incompatible Live Donor Kidney Transplantation in the US.  Journal of The American College of Surgeons.  226:615-621. 2018
    2018 Long Cold Ischemia Times in Same Hospital Deceased Donor Transplants.  Transplantation.  102:471-477. 2018
    2018 Race but not Hepatitis C co-infection affects survival of HIV+ individuals on dialysis in contemporary practice.  Kidney International.  93:706-715. 2018
    2018 Patient and Kidney Allograft Survival in Recipients with End-Stage Renal Disease from Amyloidosis.  Transplantation.  102:300-309. 2018
    2018 Living Kidney Donor Phenotype and Likelihood of Postdonation Follow-up.  Transplantation.  102:135-139. 2018
    2018 Urologic malignancies in kidney transplantation.  American Journal of Transplantation.  18:13-22. 2018
    2017 Impact of Protease Inhibitor–Based Anti-Retroviral Therapy on Outcomes for HIV+ Kidney Transplant Recipients.  American Journal of Transplantation.  17:3114-3122. 2017
    2017 Apolipoprotein L1 Gene Effects on Kidney Transplantation.  Seminars in Nephrology.  37:530-537. 2017
    2017 Expanding the use of hepatitis C–viremic kidney donors.  Kidney International.  92:1031-1033. 2017
    2017 PROviding Better ACcess To ORgans: A comprehensive overview of organ-access initiatives from the ASTS PROACTOR Task Force.  American Journal of Transplantation.  17:2546-2558. 2017
    2017 Quantifying postdonation risk of ESRD in living kidney donors.  Journal of the American Society of Nephrology.  28:2749-2755. 2017
    2017 Effect of kidney donor hepatitis C virus serostatus on renal transplant recipient and allograft outcomes..  Clinical Kidney Journal.  10:564-572. 2017
    2017 Patterns of primary care utilization before and after living kidney donation.  Clinical Transplantation.  31. 2017
    2017 Risk of End-Stage Renal Disease in HIV-Positive Potential Live Kidney Donors.  American Journal of Transplantation.  17:1823-1832. 2017
    2017 The Authors Reply.  Kidney International.  91:1256. 2017
    2017 Abdominal lean muscle is associated with lower mortality among kidney waitlist candidates.  Clinical Transplantation.  31. 2017
    2017 Obesity increases the risk of end-stage renal disease among living kidney donors.  Kidney International.  91:699-703. 2017
    2017 Survival benefit of kidney transplantation in HIV-infected patients.  Annals of Surgery.  265:604-608. 2017
    2017 Lymphocyte-depleting induction therapy lowers the risk of acute rejection in African American pediatric kidney transplant recipients.  Pediatric Transplantation.  21. 2017
    2017 Access to kidney transplantation among HIV-infected waitlist candidates.  Clinical Journal of the American Society of Nephrology.  12:467-475. 2017
    2017 Increased Mortality and Graft Loss With Kidney Retransplantation Among Human Immunodeficiency Virus (HIV)–Infected Recipients.  American Journal of Transplantation.  17:173-179. 2017
    2017 Kidney transplantation of highly sensitized recipients under the new kidney allocation system: A reflection from five different transplant centers across the United States.  Human Immunology.  78:30-36. 2017
    2017 Survival benefit of transplantation with a deceased diabetic donor kidney compared with remaining on the waitlist.  Clinical Journal of the American Society of Nephrology.  12:974-982. 2017
    2016 Overcoming immunologic barriers to kidney transplantation: Desensitization and paired donation 2016
    2016 Dosing Eculizumab for Antibody-Mediated Rejection in Kidney Transplantation: A Case Report.  Transplantation Proceedings.  48:3099-3105. 2016
    2016 Insurance Type and Solid Organ Transplantation Outcomes: A Historical Perspective on How Medicaid Expansion Might Impact Transplantation Outcomes.  Journal of The American College of Surgeons.  223:611-620.e4. 2016
    2016 Anti–Blood Group Antibodies in Intravenous Immunoglobulin May Complicate Interpretation of Antibody Titers in ABO-Incompatible Transplantation.  American Journal of Transplantation.  16:2483-2486. 2016
    2016 Identification of Optimal Donor–Recipient Combinations Among Human Immunodeficiency Virus (HIV)–Positive Kidney Transplant Recipients.  American Journal of Transplantation.  16:2377-2383. 2016
    2016 Induction Immunosuppression and Clinical Outcomes in Kidney Transplant Recipients Infected With Human Immunodeficiency Virus.  American Journal of Transplantation.  16:2368-2376. 2016
    2016 A systematic review of the use of expandable cages in the cervical spine.  Neurosurgical Review.  39:1-11. 2016
    2016 Inpatient mortality among solid organ transplant recipients hospitalized for sepsis and severe sepsis.  Clinical Infectious Diseases.  63:186-194. 2016
    2016 Long-Term outcomes after liver transplantation among human immunodeficiency virus-infected recipients.  Transplantation.  100:141-146. 2016
    2015 Center-Level Experience and Kidney Transplant Outcomes in HIV-Infected Recipients.  American Journal of Transplantation.  15:2096-2104. 2015
    2015 The biomechanics of pedicle screw augmentation with cement 2015
    2015 A Systematic Assessment of the Use of Platelet-Rich Plasma in Spinal Fusion.  Annals of Biomedical Engineering.  43:1057-1070. 2015
    2015 A national study of outcomes among HIV-infected kidney transplant recipients.  Journal of the American Society of Nephrology.  26:2222-2229. 2015
    2015 Hospital-onset Clostridium difficile infection among solid organ transplant recipients.  American Journal of Transplantation.  15:2970-2977. 2015
    2015 Identification of strategies to facilitate organ donation among african americans using the nominal group technique.  Clinical Journal of the American Society of Nephrology.  10:286-293. 2015
    2015 The impact of proposed changes in liver allocation policy on cold ischemia times and organ transportation costs.  American Journal of Transplantation.  15:541-546. 2015
    2014 The authors' reply.  Transplantation.  97. 2014
    2014 Resource utilization associated with procurement of transplantable organs from donors that do not meet OPTN eligible death criteria.  Transplantation.  97:1043-1048. 2014
    2014 Immunosuppression regimen and the risk of acute rejection in HIV-infected kidney transplant recipients.  Transplantation.  97:446-450. 2014
    2014 Eculizumab and splenectomy as salvage therapy for severe antibody-mediated rejection after HLA-incompatible kidney transplantation.  Transplantation.  98:857-863. 2014
    2014 Is there a role for detection of complement-binding antibodies in kidney transplantation?.  American Journal of Kidney Diseases.  63:558-560. 2014
    2014 To whom goes the kidney? 2014
    2013 What liver transplant outcomes can be expected in the uninsured who become insured via the affordable care act?.  American Journal of Transplantation.  13:1533-1540. 2013
    2012 Donor-derived organ transplant transmission of coccidioidomycosis.  Transplant Infectious Disease.  14:300-304. 2012
    2012 Re: Desensitization in HLA-incompatible kidney recipients and survival 2012
    2012 In vitro and ex vivo delivery of short hairpin RNAs for control of hepatitis C viral transcript expression.  Archives of Surgery.  147:384-387. 2012
    2011 Late graft loss among pediatric recipients of DCD kidneys.  Clinical Journal of the American Society of Nephrology.  6:2705-2711. 2011
    2011 Outcomes of renal transplants from centers for disease control and prevention high-risk donors with prospective recipient viral testing: A single-center experience.  Archives of Surgery.  146:1261-1266. 2011
    2011 Desensitization in HLA-incompatible kidney recipients and survival.  New England Journal of Medicine.  365:318-326. 2011
    2011 Evolving concepts in the selection of immunosuppression regimen for liver transplant recipients..  Hepatic Medicine : Evidence and Research.  3:53-62. 2011
    2010 Stem cell mobilization is life saving in an animal model of acute liver failure.  Annals of Surgery.  252:591-595. 2010
    2010 Eculizumab, bortezomib and kidney paired donation facilitate transplantation of a highly sensitized patient without vascular access.  American Journal of Transplantation.  10:2154-2160. 2010
    2010 Proinflammatory events and HLA antibodies..  American Journal of Transplantation.  10:956. 2010
    2010 Renal transplantation in HIV-positive recipients.  Current Infectious Disease Reports.  12:71-75. 2010
    2009 Impact of medicare coverage on disparities in access to simultaneous pancreas and kidney transplantation.  American Journal of Transplantation.  9:2785-2791. 2009
    2009 Increased risk of graft loss from hepatic artery thrombosis after liver transplantation with older donors 2009
    2009 Stem Cells and the Liver: Clinical Applications in Transplantation.  Advances in Surgery.  43:35-51. 2009
    2009 Successful liver transplantation for Budd-Chiari syndrome in a patient with paroxysmal nocturnal hemoglobinuria treated with the anti-complement antibody eculizumab 2009
    2009 Rapid accomodation of an a1 renal allograft after preconditioning for ABO-incompatible transplantation.  Contributions to Nephrology.  162:35-46. 2009
    2009 Recruitment of host progenitor cells in rat liver transplants.  Hepatology.  49:587-597. 2009
    2009 ABO incompatible renal transplantation: A paradigm ready for broad implementation.  Transplantation.  87:1246-1255. 2009
    2009 ABO-incompatible deceased donor liver transplantation in the United States: A national registry analysis 2009
    2009 C4d deposition without rejection correlates with reduced early scarring in ABO-incompatible renal allografts.  Journal of the American Society of Nephrology.  20:197-204. 2009
    2009 Proinflammatory events are associated with significant increases in breadth and strength of HLA-specific antibody.  American Journal of Transplantation.  9:2136-2139. 2009
    2009 Renal transplant in HIV-positive patients: Long-term outcomes and risk factors for graft loss.  Archives of Surgery.  144:83-86. 2009
    2009 The use of antibody to complement protein C5 for salvage treatment of severe antibody-mediated rejection.  American Journal of Transplantation.  9:231-235. 2009
    2008 Prolonged waiting times for liver transplantation in obese patients.  Annals of Surgery.  248:863-870. 2008
    2008 Donor ethnicity influences outcomes following deceased-donor kidney transplantation in black recipients.  Journal of the American Society of Nephrology.  19:2011-2019. 2008
    2008 Generation of humanized animal livers using embryoid body-derived stem cell transplant.  Annals of Surgery.  248:487-491. 2008
    2008 Can Machine Perfusion Decrease the Likelihood of Discard Among Biopsied Kidneys?.  Transplantation Proceedings.  40:1029-1031. 2008
    2008 Declining outcomes in simultaneous liver-kidney transplantation in the MELD era: Ineffective usage of renal allografts.  Transplantation.  85:935-942. 2008
    2008 Effect modification in liver allografts with prolonged cold ischemic time.  American Journal of Transplantation.  8:658-666. 2008
    2008 Obesity impacts access to kidney transplantation.  Journal of the American Society of Nephrology.  19:349-355. 2008
    2007 ABO-incompatible transplantation: Less may be more.  Transplantation.  84. 2007
    2007 Minimizing risk associated with elderly liver donors by matching to preferred recipients.  Hepatology.  46:1907-1918. 2007
    2007 Twenty years of liver transplantation for Budd-Chiari syndrome: A national registry analysis 2007
    2007 Desensitization protocols for crossing human leukocyte antigen and ABO incompatible barriers.  Current Opinion in Organ Transplantation.  12:371-378. 2007
    2007 Outcomes of kidneys from donors after cardiac death: Implications for allocation and preservation.  American Journal of Transplantation.  7:1797-1807. 2007
    2007 The utility of splenectomy as rescue treatment for severe acute antibody mediated rejection.  American Journal of Transplantation.  7:842-846. 2007
    2007 Cold ischemia time and allograft outcomes in live donor renal transplantation: Is live donor organ transport feasible?.  American Journal of Transplantation.  7:99-107. 2007
    2006 Factors affecting graft survival after liver transplantation from donation after cardiac death donors.  Transplantation.  82:1683-1688. 2006
    2006 Biliary cystic disease.  Current Treatment Options in Gastroenterology.  9:107-112. 2006
    2006 Rescue splenectomy for severe acute antibody-mediated rejection..  Clinical Transplants.  518-520. 2006
    2005 Inflammatory pseudotumor of the liver.  Journal of Hepato-Biliary-Pancreatic Surgery.  12:314-316. 2005

    Chapter

    Year Title Altmetric
    2019 Kidney allocation.  371-378. 2019
    2015 Management of Portal Hypertensive Hemorrhage.  510-513. 2015
    2012 Consider parvovirus B19 infection in patients with anemia or pancytopenia 2012
    2012 Keep patients with dural tears flat for 24-48 hours 2012
    2012 Place the tip of a central venous catheter at the junction of the superior vena cava and atrium 2012

    Research Overview

  • abdominal transplantation, incompatible organ transplantation, transplantation of HIV-infected end-stage patients, outcomes and behavioral research focused on health disparities

    • Principal Investigator On

  • Genetic, Environmental & Histologic Basis for Kidney Disease Risk among Persons Living with HIV  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS 2020 - 2025
  • CKD Risk Prediction among Obese Living Kidney Donors  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS 2017 - 2022
  • Private Grant  awarded by LUNG BIOTECHNOLOGY PBC 2020 - 2022
  • Expanding Live Donor Kidney Transplantation Through Advocacy Training and Social Media  awarded by Johns Hopkins University 2017 - 2022
  • Private Grant  awarded by LUNG BIOTECHNOLOGY PBC 2020 - 2021
  • HOPE in Action: A Clinical Trial of HIV-to-HIV Liver Transplantation  awarded by Johns Hopkins University 2019 - 2021
  • Establishing Cultural Competent Educational Standards for Living Kidney Donors  awarded by American College of Surgeons 2019 - 2021
  • Social Network Interventions to Reduce Race Disparities in Living Kidney Donation  awarded by Pennsylvania State University 2017 - 2021
  • Private Grant  awarded by LUNG BIOTECHNOLOGY PBC 2020 - 2021
  • Private Grant  awarded by LUNG BIOTECHNOLOGY PBC 2020
  • Long-Term Outcomes Among Living Kidney Donors with Isolated Medical Abnormalities  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS 2015 - 2020
  • Genetic, Environmental & Histologic Basis for Kidney Disease Risk among Persons Living with HIV  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS 2018 - 2019
  • Long-Term Outcomes after Live Kidney Donation among Donors with Isolated Medical Abnormalities  awarded by American Society of Transplantation 2014 - 2016
  • Health Services Foundation-General Endowment Fund Scholar Award  awarded by UNIVERSITY OF ALABAMA HEALTH SERVICES FOUNDATION 2013 - 2016

    • Investigator On

  • Interdisciplinary Training In Kidney-Related Research  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS 2019 - 2024
  • Short-Term Research Experiences Advancing Medical Students (STREAMS)  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS 2019 - 2024
  • APOL1 Long-Term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS 2019 - 2022
  • APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS 2017 - 2022
  • Effects of Inhibiting Early Inflammation in Kidney Transplant Patients  awarded by ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI 2019 - 2021
  • Impact of CCR5 Blockade in HIV+Kidney Transplant Recipients  awarded by University of California, San Francisco 2019 - 2021
  • HOPE in Action: A Clinical Trial of HIV-to-HIV Deceased Donor Kidney Transplantation  awarded by Johns Hopkins University 2018 - 2021
  • Identification of Drugs that Induce Terminal Transcriptional Silencing of Latent HIV-1 Infection  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2017 - 2021
  • Implications of Donor Methamphetamine Use in Deceased Donor Liver, Pancreas, and Small Bowel Transplantation  awarded by Society for Surgery of the Alimentary Tract 2019 - 2021
  • PRedoctoral Interdisciplinary Training in Renal Physiology and MEdIcIne (PRIME)  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS 2018 - 2021
  • Evaluating the Implementation and Effectiveness of the Living Donor Navigator Program  awarded by American Society of Nephrology 2018 - 2020
  • Private Grant  awarded by ASTELLAS PHARMA US, INC. 2017 - 2020
  • Private Grant  awarded by ASTELLAS PHARMA GLOBAL DEVELOPMENT, INC. - NEW 2018 - 2019
  • Private Grant  awarded by LUNG BIOTECHNOLOGY PBC 2015 - 2019
  • Effects of Inhibiting Early Inflammation in Kidney Transplant Patients - Equipment  awarded by Mount Sinai School of Medicine 2015 - 2019
  • Impact of CCR5 Blockade in HIV + Kidney Transplant Recipients  awarded by University of California, San Francisco 2016 - 2019
  • Prospective Observational Study of HIV+ Deceased Donor Transplant for HIV+ Recipients  awarded by Johns Hopkins University 2018 - 2019
  • APOL1 Long-Term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS 2019
  • Private Grant  awarded by QUARK PHARMACEUTICALS, INC. 2015 - 2019
  • Comparison of Immune Globulin Intravenous (Human), 10% (IVIG), plus Rituximab vs. IVIG 10% + Placebo (Normal Saline) as Agents to Reduce Donor Specific Antibodies, Improve Transplant Rates and Outcomes in Highly-HLA Sensitized Patients Awaiting Deceased Donor Kidney Transplantation  awarded by Cedars - Sinai Medical Center 2014 - 2019
  • Private Grant  awarded by ASTELLAS PHARMA US, INC. 2013 - 2017
  • Private Grant  awarded by ALEXION PHARMACEUTICALS, INC. 2014 - 2017
  • Preserving Renal Function & Protective Immunity via Anti-LFA-1-Based CNI Avoidance  awarded by Emory University 2009 - 2016
  • Private Grant  awarded by ALEXION PHARMACEUTICALS, INC. 2013 - 2016
  • Comparison of Immune Globulin Intravenous (Human), 10% (IVIG), plus Rituximab vs. IVIG 10% + Placebo (Normal Saline) as Agents to Reduce Donor Specific Antibodies, Improve Transplant Rates and Outcomes in Highly-HLA Sensitized Patients Awaiting Deceased Donor Kidney Transplantation  awarded by Cedars - Sinai Medical Center 2014

    • Education And Training

  • Doctor of Medicine, East Carolina University 2002
  • Johns Hopkins Hospital, Residency 2010
  • Johns Hopkins Hospital, Postdoctoral Fellowship 2012

    • Full Name

  • Jayme Locke